These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia]. Ono R Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2084-9. PubMed ID: 12187682 [No Abstract] [Full Text] [Related]
27. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy]. Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186 [No Abstract] [Full Text] [Related]
28. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84. Ortega JJ; Javier G; Olivé T An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043 [No Abstract] [Full Text] [Related]
29. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside]. Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900 [No Abstract] [Full Text] [Related]
32. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules. Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707 [No Abstract] [Full Text] [Related]
33. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy. Uzuka Y; Liong SK; Yamagata S Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159 [TBL] [Abstract][Full Text] [Related]
34. [FAB classification, response to therapy, and survival in adult patients with acute leukemia]. Moriyama Y; Aoki S; Urushiyama M; Ohnishi M; Hirosawa H; Koyama S; Hanano M; Fuse I; Takai K; Nagayama R; Fujiwara M; Kishi K; Takahashi M; Koike T; Sakai C; Kashimura M; Takahashi H; Miura R; Aoyagi A; Sanada M; Hattori A; Shibata A; Shinada S Rinsho Ketsueki; 1982 Nov; 23(11):1706-12. PubMed ID: 6962910 [No Abstract] [Full Text] [Related]
35. [Significance of the synchronization of the leukemic cell population in the therapy of patients with acute leukemia]. Kovaleva LG; Kozinets GI; Al'perovich VV; Faĭnshteĭn FE Probl Gematol Pereliv Krovi; 1975 Mar; 20(3):3-7. PubMed ID: 1219717 [No Abstract] [Full Text] [Related]
36. Proliferation kinetics and prediction of chemotherapeutic effect in adult acute leukemia according to the FAB classification. Tsubaki K; Horiuchi A Nihon Ketsueki Gakkai Zasshi; 1984 Sep; 47(6):1322-9. PubMed ID: 6542735 [No Abstract] [Full Text] [Related]
37. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503 [TBL] [Abstract][Full Text] [Related]
38. [A case of leukemia obtained complete remission after delivery (author's transl)]. Handa M; Negishi M; Suzuki H; Toyama K; Udagawa Y; Nemato K; Goto M Rinsho Ketsueki; 1978 Apr; 19(4):351-5. PubMed ID: 702817 [No Abstract] [Full Text] [Related]
39. [Treatment of acute myeloblastic leukemia. Evaluation of six years of cooperative studies in Argentina (author's transl)]. Pavlovsky S; Eppinger-Helft M; Sackmann Muriel F; Suarez A; Pavlovsky A; Hidalgo G; Vilaseca G; Macchi A; Bergna L Sangre (Barc); 1974; 19(2):166-76. PubMed ID: 4528361 [No Abstract] [Full Text] [Related]
40. [State of the art of chemotherapy for adult acute leukemia in Japan]. Ohno R Gan To Kagaku Ryoho; 1993 Dec; 20(16):2478-82. PubMed ID: 8279845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]